Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
Changes in microRNA (miRNA) expression may lead to cancer development and/or contribute to its progression; however, their role in uterine sarcomas is poorly understood. Uterine sarcomas (US) belong to a rare class of heterogeneous tumors, representing about 1% of all gynecologic neoplasms. This stu...
Main Authors: | Laura Gonzalez dos Anjos, Bruna Cristine de Almeida, Thais Gomes de Almeida, André Mourão Lavorato Rocha, Giovana De Nardo Maffazioli, Fernando Augusto Soares, Isabela Werneck da Cunha, Edmund Chada Baracat, Katia Candido Carvalho |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/10/9/315 |
Similar Items
-
miRNA: A Promising Therapeutic Target in Cancer
by: Amrutha Menon, et al.
Published: (2022-09-01) -
Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review
by: Shadab Md, et al.
Published: (2021-12-01) -
MiRNA as a Potential Target for Multiple Myeloma Therapy–Current Knowledge and Perspectives
by: Aneta Szudy-Szczyrek, et al.
Published: (2022-08-01) -
Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma
by: Chia-Hsin Liu, et al.
Published: (2022-01-01) -
Identification of miRNA precursors in the phloem of Cucurbita maxima
by: Eugeny Tolstyko, et al.
Published: (2019-12-01)